Financial Data and Key Metrics Changes - Adjusted funds from operations (AFFO) for Q1 2025 were $0.75 per share, and funds available for distribution (FAD) were $0.71 per share, reflecting revenue and EBITDA growth, with leverage reduced to 3.7x debt to EBITDA [5][12] - Revenue for Q1 2025 was $277 million, up from $243 million in Q1 2024, primarily due to new investments and operator restructurings [9] - Net income for Q1 2025 was $112 million or $0.33 per share, compared to $69 million or $0.27 per share in Q1 2024 [10] Business Line Data and Key Metrics Changes - The percentage of private pay and other revenue increased from 8% ten years ago to 39% today, with expectations for continued growth in this area [8] - Maplewood paid $15.6 million in rent in Q1 2025, an increase of $3.3 million from Q4 2024, and occupancy for the Maplewood portfolio reached 94% as of April 2025 [20] Market Data and Key Metrics Changes - The UK market accounted for approximately 93% of total new investments in Q1 2025, with a strong pipeline of opportunities [23][25] - The trailing twelve-month operator EBITDAR coverage for the core portfolio increased to 1.51x as of December 31, 2024, indicating improved performance [18] Company Strategy and Development Direction - The company is focused on disciplined and sustainable investment decisions while expanding its operator base in both the US and UK markets [18][24] - Omega is looking to opportunistically fund investments with equity, positioning itself for outsized adjusted FFO growth [13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability of Genesis to continue paying rent despite recent liquidity issues, citing strong coverage metrics [6][33] - The company remains optimistic about the overall coverage and fundamentals improving in the healthcare sector, despite potential Medicaid cuts [28][29] Other Important Information - The company raised and narrowed its full-year adjusted FFO guidance to a range between $2.95 to $3.01 per share [14] - The company has a strong balance sheet with $368 million in cash and full borrowing capacity of its $1.45 billion credit facility [12] Q&A Session Summary Question: Details on Genesis and its rent payment issues - Management indicated that Genesis's recent rent payment issues were a one-time event related to their ABL lender tightening availability, and they expect continued payments moving forward [31][33] Question: Insights on the UK portfolio acquisition - The UK acquisition was facilitated by a strong platform and relationships with multiple operators, allowing for a quick and efficient transaction [39][41] Question: Impact of immigration on labor availability - No significant impact on labor availability or wage pressures has been observed at this time [45] Question: Genesis's operating fundamentals - Coverage metrics for Genesis have improved, with the portfolio consistently above 1.5 times [47] Question: Provider tax and Medicaid changes - The greatest risk to traditional Medicaid is provider taxes, which may see slight reductions, but the overall impact remains uncertain [76][78] Question: Disposition strategy and market opportunities - The company executed dispositions to redeploy capital effectively, taking advantage of attractive offers for non-core assets [82][84]

Financial Data and Key Metrics Changes - Adjusted funds from operations (AFFO) for Q1 2025 were $0.75 per share, and funds available for distribution (FAD) were $0.71 per share, reflecting revenue and EBITDA growth [6][11] - Revenue for Q1 2025 was $277 million, up from $243 million in Q1 2024, primarily due to new investments and operator restructurings [10] - Net income for Q1 2025 was $112 million, or $0.33 per share, compared to $69 million, or $0.27 per share, in Q1 2024 [10][11] - NAREIT FFO for Q1 was $184 million, or $0.62 per share, compared to $153 million, or $0.60 per share, in Q1 2024 [11] Business Line Data and Key Metrics Changes - The percentage of private pay and other revenue increased from 8% ten years ago to 39% today, with expectations for continued growth [9] - Maplewood's occupancy for its core portfolio reached 94% as of April 2025, with rent payments improving significantly [20] Market Data and Key Metrics Changes - The trailing twelve-month operator EBITDAR coverage for the core portfolio increased to 1.51x as of December 31, 2024, compared to 1.50x for the previous period [18] - Omega's investment activity in Q1 2025 included over $423 million in new real estate investments and $34 million in CapEx investments [22] Company Strategy and Development Direction - The company raised and narrowed its full-year adjusted FFO guidance to a range between $2.95 to $3.01 per share, assuming no change in revenue related to operators [14] - Omega is focusing on disciplined and sustainable investment decisions while serving a complex resident population across various asset types and markets [19] - The company continues to prioritize capital allocation towards accretive owned real estate deals that grow its balance sheet [26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the ability of Genesis to continue paying rent, despite recent liquidity issues [7][35] - The company remains optimistic about the overall coverage and fundamentals improving, with no significant changes expected in the lending environment [29][63] - Management is closely monitoring potential Medicaid reforms and their implications for the business [29][81] Other Important Information - The company completed a $344 million investment for a portfolio of 45 care homes across the UK and Jersey, with an initial cash yield of 10% [24] - The federal judge ruled in favor of the industry regarding staffing mandates, which is expected to save the federal government $22 billion over ten years [28] Q&A Session Summary Question: Details on Genesis not paying rent and interest in March - Management indicated that Genesis has a weak balance sheet, and the shortfall was a one-time issue related to their ABL lender [34][36] Question: More details on the UK portfolio acquisition - The acquisition involved six operators and was completed quickly due to the company's strong platform in the UK [41][42] Question: Impact of immigration on labor availability and wage pressures - Management has not seen any significant impact from immigration on labor availability or wage pressures at this time [46] Question: Genesis operating fundamentals - Coverage metrics for Genesis have improved, with the portfolio consistently above 1.5 times [47] Question: Cap rates for yields on first quarter dispositions - Management indicated that the dispositions were both opportunistic and part of a cleanup of non-core assets [85]

Core Points - Healthcare Realty Trust reported a net loss attributable to common stockholders of $(44.9) million, or $(0.13) per diluted common share for Q1 2025 [1][19] - The company declared a quarterly dividend of $0.31 per share, payable on May 23, 2025 [3] - The company reaffirmed its earnings per share guidance for 2025, with a range of $(0.28) to $(0.20) [4] Leasing - Portfolio leasing activity in Q1 2025 totaled 1,450,000 square feet across 377 leases, including 1,002,000 square feet of renewals and 448,000 square feet of new and expansion leases [5] - The company signed new leases totaling 370,000 square feet in the first quarter [5] Same Store Metrics - Same store occupancy increased to 89.3% as of the end of Q1 2025, up from 89.2% in Q4 2024 [5] - Tenant retention improved to 84.8% in Q1 2025, compared to 81.6% in Q4 2024 [5] Balance Sheet - Total assets decreased to $10.5 billion in Q1 2025 from $10.7 billion in Q4 2024 [14][15] - Total liabilities remained relatively stable at $5.3 billion in Q1 2025, compared to $5.3 billion in Q4 2024 [15] Leadership - Peter A. Scott was appointed as President & CEO effective April 15, 2025, succeeding Connie Moore, who served as Interim President and CEO [5] Dividend - The company will pay a cash dividend of $0.31 per share on May 23, 2025, to Class A common stockholders of record on May 12, 2025 [3] Guidance - The company provided guidance for 2025, with expected earnings per share ranging from $(0.28) to $(0.20) and NAREIT FFO per share between $1.44 and $1.48 [4]